PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $417,500 | -37.2% | 50,000 | 0.0% | 0.09% | -36.7% |
Q2 2023 | $665,000 | +14.9% | 50,000 | 0.0% | 0.15% | +5.8% |
Q1 2023 | $579,000 | +41.6% | 50,000 | 0.0% | 0.14% | +35.0% |
Q4 2022 | $409,000 | +41.0% | 50,000 | 0.0% | 0.10% | +30.4% |
Q3 2022 | $290,000 | +31.2% | 50,000 | 0.0% | 0.08% | +41.1% |
Q2 2022 | $221,000 | -51.4% | 50,000 | 0.0% | 0.06% | -39.8% |
Q1 2022 | $455,000 | -55.5% | 50,000 | 0.0% | 0.09% | -39.6% |
Q4 2021 | $1,023,000 | -20.0% | 50,000 | 0.0% | 0.15% | -43.8% |
Q3 2021 | $1,278,000 | -26.9% | 50,000 | 0.0% | 0.27% | -22.8% |
Q2 2021 | $1,749,000 | +5.0% | 50,000 | 0.0% | 0.36% | -4.6% |
Q1 2021 | $1,666,000 | – | 50,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |